Antipseudomonal Agents Exhibit Differential Pharmacodynamic Interactions with Human Polymorphonuclear Leukocytes against Established Biofilms of Pseudomonas aeruginosa

作者: Athanasios Chatzimoschou , Maria Simitsopoulou , Charalampos Antachopoulos , Thomas J. Walsh , Emmanuel Roilides

DOI: 10.1128/AAC.04934-14

关键词:

摘要: Pseudomonas aeruginosa is the most common pathogen infecting lower respiratory tract of cystic fibrosis (CF) patients, where it forms tracheobronchial biofilms. biofilms are refractory to antibacterials and phagocytic cells with innate immunity, leading infection. Little known about interaction between antipseudomonal agents in eradication P. Herein, we investigated capacity three agents, amikacin (AMK), ceftazidime (CAZ), ciprofloxacin (CIP), interact human polymorphonuclear leukocytes (PMNs) against planktonic isolates recovered from sputa CF patients. Three were resistant susceptible each these antibiotics. The concentrations studied (2, 8, 32 mg/liter) subinhibitory for isolates, whereas they ranged sub-MIC 2 × MIC values. activity antibiotic alone or combination PMNs 48-h mature was determined by XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide] assay. All combinations AMK resulted synergistic additive effects compared component alone. More than 75% CAZ exhibited interactions CIP had mostly antagonistic no aeruginosa. Our findings demonstrate a greater positive that observed especially

参考文章(50)
Thomas Bjarnsholt, Peter Østrup Jensen, Mette Burmølle, Morten Hentzer, Janus A. J. Haagensen, Hans Petter Hougen, Henrik Calum, Kit G. Madsen, Claus Moser, Søren Molin, Niels Høiby, Michael Givskov, Pseudomonas aeruginosa tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leukocytes is quorum-sensing dependent Microbiology. ,vol. 151, pp. 373- 383 ,(2005) , 10.1099/MIC.0.27463-0
Luke A. Garske, Scott A. Beatson, Andrew J. Leech, Shannon L. Walsh, Scott C. Bell, Sub‐inhibitory concentrations of ceftazidime and tobramycin reduce the quorum sensing signals of Pseudomonas aeruginosa Pathology. ,vol. 36, pp. 571- 575 ,(2004) , 10.1080/00313020400011300
J. Foweraker, Recent advances in the microbiology of respiratory tract infection in cystic fibrosis. British Medical Bulletin. ,vol. 89, pp. 93- 110 ,(2008) , 10.1093/BMB/LDN050
Johanna Goldfarb, Gary P. Wormser, Mario A. Inchiosa, Giancarlo Guideri, Magaly Diaz, Ruta Gandhi, Carey Goltzman, Armond V. Mascia, Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis. The Journal of Clinical Pharmacology. ,vol. 26, pp. 222- 226 ,(1986) , 10.1002/J.1552-4604.1986.TB02938.X
Nicky C. Caiazza, Judith H. Merritt, Kimberly M. Brothers, George A. O'Toole, Inverse Regulation of Biofilm Formation and Swarming Motility by Pseudomonas aeruginosa PA14 Journal of Bacteriology. ,vol. 189, pp. 3603- 3612 ,(2007) , 10.1128/JB.01685-06
Peter Ø Jensen, Thomas Bjarnsholt, Richard Phipps, Thomas B Rasmussen, Henrik Calum, Lars Christoffersen, Claus Moser, Paul Williams, Tacjana Pressler, Michael Givskov, Niels Høiby, None, Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology. ,vol. 153, pp. 1329- 1338 ,(2007) , 10.1099/MIC.0.2006/003863-0
Marie-Thérèse Labro, Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents Expert Review of Anti-infective Therapy. ,vol. 10, pp. 319- 340 ,(2012) , 10.1586/ERI.12.11
Athanasios Chatzimoschou, Αspasia Katragkou, Maria Simitsopoulou, Charalampos Antachopoulos, Elpiniki Georgiadou, Thomas J. Walsh, Emmanuel Roilides, Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells Antimicrobial Agents and Chemotherapy. ,vol. 55, pp. 1968- 1974 ,(2011) , 10.1128/AAC.00959-10
Mette E Skindersoe, Morten Alhede, Richard Phipps, Liang Yang, Peter O Jensen, Thomas B Rasmussen, Thomas Bjarnsholt, Tim Tolker-Nielsen, Niels Høiby, Michael Givskov, None, Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa Antimicrobial Agents and Chemotherapy. ,vol. 52, pp. 3648- 3663 ,(2008) , 10.1128/AAC.01230-07